Is there a time limit for systemic menopausal hormone therapy?

Laura Dorr Lipold; Pelin Batur; Risa Kagan

doi:10.3949/ccjm.83a.15161

Is there a time limit for systemic menopausal hormone therapy?

Cleve Clin J Med. 2016 Aug;83(8):605-12. doi: 10.3949/ccjm.83a.15161.

Authors

Laura Dorr Lipold^{1

2}, Pelin Batur^{3

4

2}, Risa Kagan⁵

Affiliations

¹ Director, Primary Care Women's Health, Medicine Institute, Cleveland Clinic Beachwood Family Health Center, Beachwood, OH, USA. E-mail: dorrl@ccf.org.
² Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
³ Education Director, Primary Care Women's Health, Department of Community Internal Medicine, Cleveland Clinic, Independence, OH, USA.
⁴ Deputy Editor, Cleveland Clinic Journal of Medicine, Lyndhurst, OH, USA.
⁵ Clinical Professor, University of California, San Francisco, CA, USA.

PMID: 27505882
DOI: 10.3949/ccjm.83a.15161

Abstract

In deciding whether it is time to stop hormone therapy, in addition to the patient's age we need to consider her preferences, symptoms, quality of life, time since menopause, hysterectomy status, and personal risks of osteoporosis, breast cancer, heart disease, stroke, and venous thromboembolism. This article presents the evidence for and against extending hormone therapy and a guide for making this highly individualized and shared decision.

Publication types

Review

MeSH terms

Estrogen Replacement Therapy / methods*
Estrogens / administration & dosage
Female
Humans
Menopause*
Middle Aged
Risk Assessment / methods*
Time Factors*
Withholding Treatment / standards*

Substances

Estrogens